Why the study?
Does propranolol alter sympathovagal balance in patients with Graves' hyperthyroidism?
Does propranolol alter sympathovagal balance in patients with Graves' hyperthyroidism?
In patients with Graves' hyperthyroidism, sympathovagal imbalance is driven by increased sympathetic activity and diminished vagal tone, which is not reversed by beta-blockade despite heart rate reduction.
Propranolol reduces heart rate without normalizing HRV in Graves' hyperthyroidism; leaves open whether sympathovagal imbalance requires non-beta-adrenergic interventions.
We assessed sympathovagal balance in thyrotoxicosis. Fourteen patients with Graves' hyperthyroidism were studied before and after 7 days of treatment with propranolol (40 mg 3 times a day) and in the euthyroid state. Data were compared with those obtained in a group of age-, sex-, and weight-matched controls. Autonomic inputs to the heart were assessed by power spectral analysis of heart rate variability. Systemic exposure to sympathetic neurohormones was estimated on the basis of 24-h urinary catecholamine excretion. The spectral power in the high-frequency domain was considerably reduced in hyperthyroid patients, indicating diminished vagal inputs to the heart. Increased heart rate and mid-frequency/high-frequency power ratio in the presence of reduced total spectral power and increased urinary catecholamine excretion strongly suggest enhanced sympathetic inputs in thyrotoxicosis. All abnormal features of autonomic balance were completely restored to normal in the euthyroid state. beta-Adrenoceptor antagonism reduced heart rate in hyperthyroid patients but did not significantly affect heart rate variability or catecholamine excretion. This is in keeping with the concept of a joint disruption of sympathetic and vagal inputs to the heart underlying changes in heart rate variability. Thus thyrotoxicosis is characterized by profound sympathovagal imbalance, brought about by increased sympathetic activity in the presence of diminished vagal tone.
No takes yet. Share an insight, caveat, or question.
Burggraaf et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: